Soluble Interleukin-2 Receptor Is a Promising Serum Biomarker for Granulomatous Disease in Common Variable Immune Deficiency

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)
15 Downloads (Pure)
Original languageEnglish
Pages (from-to)694-697
Number of pages4
JournalJournal of Clinical Immunology
Volume41
Issue number3
DOIs
Publication statusPublished - 6 Jan 2021

Research programs

  • EMC OR-01

Cite this